483 related articles for article (PubMed ID: 27403030)
41. Screening and detection of hepatocellular carcinoma.
Simpson HN; McGuire BM
Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
[TBL] [Abstract][Full Text] [Related]
42. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
43. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
[TBL] [Abstract][Full Text] [Related]
44. Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma.
Zhang Y; Liu Z; Ji K; Li X; Wang C; Ren Z; Liu Y; Chen X; Han X; Meng L; Li L; Li Z
Front Mol Biosci; 2021; 8():736330. PubMed ID: 34660697
[TBL] [Abstract][Full Text] [Related]
45. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
46. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
47. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.
Sugimachi K; Matsumura T; Hirata H; Uchi R; Ueda M; Ueo H; Shinden Y; Iguchi T; Eguchi H; Shirabe K; Ochiya T; Maehara Y; Mimori K
Br J Cancer; 2015 Feb; 112(3):532-8. PubMed ID: 25584485
[TBL] [Abstract][Full Text] [Related]
48. An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer.
Espinoza AF; Kureti P; Patel RH; Do SL; Govindu SR; Armbruster BW; Urbicain M; Patel KR; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727682
[TBL] [Abstract][Full Text] [Related]
49. Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.
Awan FM; Naz A; Obaid A; Ali A; Ahmad J; Anjum S; Janjua HA
PLoS One; 2015; 10(9):e0138913. PubMed ID: 26414287
[TBL] [Abstract][Full Text] [Related]
50. Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Ogle LF; Orr JG; Willoughby CE; Hutton C; McPherson S; Plummer R; Boddy AV; Curtin NJ; Jamieson D; Reeves HL
J Hepatol; 2016 Aug; 65(2):305-13. PubMed ID: 27132171
[TBL] [Abstract][Full Text] [Related]
51. Classifying circulating tumor cells to monitor cancer progression.
Economopoulou P; Georgoulias V; Kotsakis A
Expert Rev Mol Diagn; 2017 Feb; 17(2):153-165. PubMed ID: 28032524
[TBL] [Abstract][Full Text] [Related]
52. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.
Jiang P; Sun K; Tong YK; Cheng SH; Cheng THT; Heung MMS; Wong J; Wong VWS; Chan HLY; Chan KCA; Lo YMD; Chiu RWK
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10925-E10933. PubMed ID: 30373822
[TBL] [Abstract][Full Text] [Related]
53. Circulating markers for prognosis of hepatocellular carcinoma.
Wong KF; Xu Z; Chen J; Lee NP; Luk JM
Expert Opin Med Diagn; 2013 Jul; 7(4):319-29. PubMed ID: 23642136
[TBL] [Abstract][Full Text] [Related]
54. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives.
Bardol T; Pageaux GP; Assenat E; Alix-Panabières C
Clin Chem; 2024 Jan; 70(1):33-48. PubMed ID: 37962158
[TBL] [Abstract][Full Text] [Related]
55. Circulating Hepatocellular Cells are a Bad Prognostic Factor for HCC Patients.
Liu Y; Wang YR; Wang L; Xun LJ; Ding GH; Yao L
Hepatogastroenterology; 2015 Jun; 62(140):802-6. PubMed ID: 26902005
[TBL] [Abstract][Full Text] [Related]
56. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
[TBL] [Abstract][Full Text] [Related]
57. High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation.
Cho HJ; Kim JK; Nam JS; Wang HJ; Lee JH; Kim BW; Kim SS; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
Clin Biochem; 2015 Nov; 48(16-17):1073-8. PubMed ID: 26129878
[TBL] [Abstract][Full Text] [Related]
58. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
Mezzalira S; De Mattia E; Guardascione M; Dalle Fratte C; Cecchin E; Toffoli G
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694149
[TBL] [Abstract][Full Text] [Related]
59. Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma.
Li X; Wang H; Li T; Wang L; Wu X; Liu J; Xu Y; Wei W
Curr Probl Cancer; 2020 Apr; 44(2):100516. PubMed ID: 31836136
[TBL] [Abstract][Full Text] [Related]
60. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
